ABINGDON, UK – Green Biologics Limited (GBL), a UK-based industrial biotechnology company, announced the merger between GBL and butylfuel™ Inc., a U.S.-based renewable chemicals and biofuels company. The new company will operate under the Green Biologics name and continue to be headquartered in Abingdon, UK, with a strong operational presence and commercial focus in the United States contributed by butylfuel™ Inc., which will become Green Biologics Inc. The merger became effective January 1, 2012.
“This merger creates a truly global leader in biobutanol and represents a transformational deal for both companies,” said Sean Sutcliffe, CEO of the combined GBL group. “We are combining GBL’s acknowledged technology leadership and commercialization expertise in China, India and Brazil with the scale-up, operational process experience and North American business building capabilities of butylfuel™.”